Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

IL-15 exerts potent antiapoptotic effects in vivo

Oct. 27, 1997

Anti-H. pylori cephems claimed by Fujisawa

Oct. 24, 1997

Janssen discloses agents that promote gastrointestinal motility

Oct. 24, 1997

Promising clinical trial results reported for Medeva's Hepagene as vaccine and treatment

Oct. 23, 1997

Axcan completes phase III trial for H. pylori eradication

Oct. 22, 1997

OraVax to develop new treatments for Clostridium difficile-associated disease

Oct. 22, 1997

Diagnon receives NCI grant for H. pylori research

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...